Orthopediatrics (KIDS) Cash & Equivalents (2016 - 2026)

Orthopediatrics (KIDS) has reported Cash & Equivalents for 11 consecutive years, with $12.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents fell 63.54% year-over-year to $12.2 million; the TTM figure through Mar 2026 stood at $12.2 million (down 63.54% YoY), while the FY2025 annual figure was $19.6 million, down 55.37% from the prior year.
• Cash & Equivalents retreated to $12.2 million in Q1 2026 per KIDS's latest filing, from $19.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $51.0 million in Q3 2024 and bottomed at $9.0 million in Q4 2022.
• Historically, Cash & Equivalents has averaged $26.4 million across 5 years, with a median of $25.3 million in 2024.
• Annual changes were most pronounced in 2023 — Cash & Equivalents plunged 73.89% — and 2024, when it jumped 379.77%.
• Orthopediatrics' Cash & Equivalents stood at $9.0 million in 2022, then jumped by 245.4% to $31.1 million in 2023, then soared by 41.1% to $43.8 million in 2024, then slumped by 55.37% to $19.6 million in 2025, then slumped by 37.65% to $12.2 million in 2026.
• Business Quant data shows KIDS's Cash & Equivalents at $12.2 million in Q1 2026, $19.6 million in Q4 2025, and $16.8 million in Q3 2025.